Ontario
我们是谁
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver
INCB099280 联合 Adagrasib 治疗携带 KRASG12C 突变的晚期实体瘤成人研究
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator’s Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) ( CheckMate 8HW )
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008)
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer ( SEAMARK )
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
一项针对转移性结直肠癌晚期患者的 Nivolumab-relatlimab 固定剂量联合疗法对比瑞戈非尼或 TAS-102 的研究
